Inhibition of hormone-stimulated hepatic glycogenolysis by fructose (Fru) has been attributed to accumulation of the competitive inhibitor Fru1P and/or to the associated depletion of the substrate phosphate (P i ). To evaluate the relative importance of either factor, we used the Fru analogue 2,5-an
✦ LIBER ✦
Apparent dose dependency of the hepatic (S)-acenocoumarol clearance in the rat: A study using open liver biopsies
✍ Scribed by M. J. A. P. Daemen; H. T. M. Vervoort-Peters; H. H. W. Thijssen
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 343 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
On the inhibition of hepatic glycogenoly
✍
K. Bruynseels; N. Bergans; N. Gillis; F. van Dorpen; P. Van Hecke; W. Stalmans;
📂
Article
📅
1999
🏛
John Wiley and Sons
🌐
English
⚖ 156 KB
👁 2 views
Assessing symptom burden using the M. D.
✍
Janice L. Gabrilove; Edith A. Perez; Dianne K. Tomita; Greg Rossi; Charles S. Cl
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 346 KB
## Abstract ## BACKGROUND. Patients with cancer who are receiving chemotherapy often experience chemotherapy‐induced anemia (CIA), which is associated with symptoms that reduce quality of life. The M. D. Anderson Symptom Inventory (MDASI) is a brief, self‐rating assessment scale that measures the